News

Filter by date
Aquadetrim wins SmartPharmaAwards 2023 in the nomination Source of vitamin D3 for children from the first year of life.
09.06.2023
Akrikhin’s product portfolio wins a second prize in the nomination Pharmacist’s choice: INN generics I trust.
PHARMACEUTICAL COMPANY AKRIKHIN ONCE AGAIN SUPPORTS THE INTERNATIONAL STUDENT FESTIVAL GXP FEST IN 2023
23.05.2023
For two years in a row, Akrikhin has acted as a partner of GxP Fest international festival for undergraduate and graduate students and faculty of pharmaceutical higher education institutions. The event program included presentations, master classes, meeting with the industry experts, as well as presentation of possible internships in the company for young professionals.
EFFICIENT BUSINESS SOLUTIONS FOR THE RUSSIAN PHARMA: AN INTERVIEW WITH DENIS CHETVERIKOV, Akrikhin
19.05.2023
​​On May 16–17, 2023 St. Petersburg will host an anniversary 30th Russian Pharmaceutical Forum named after N.A.
Semashko. The  annual meeting will traditionally bring together the managers of the  leading international and Russian pharmaceutical companies,  representatives  of regulatory authorities, professional associations, research  organizations and the patient community.
ORGANIZATIONAL CHANGES AND NEW APPOINTMENTS AT AKRIKHIN
17.02.2023
Akrikhin continues to strengthen its internal organization and focus on the development of key business segments. To this end, the company has undergone personnel changes: a new commercial director and vice president for generic drugs have been appointed.
AKRIKHIN IS AMONG THE TOP 100 BEST EMPLOYERS OF RUSSIA 2022
13.02.2023
Akrikhin has been included into the annual Rating of Russian Employers-2022 presented by the HeadHunter recruiting service, and ranks 3rd among major employers in medicine and pharmacy. The shortlist of the rating includes over 1,000 companies from different industries of the Russian market.
We use cookies to improve your experience on our site and to show you personalised advertising. By pressing “I AGREE” you accept our cookies policy.
To find out more, go to cookies policy.
I AGREE